Dr Vikram Jain

Q9 - Services for partners

Professor Phillip Good touches upon the available support for carers, both during the illness of the person they care for and after their death. He discusses the emotional difficulties that carers, particularly men, have to deal with and stresses the significance of finding a service that is well-suited to the individual’s needs. Dr. Rebecca Moor contributes by sharing certain services that have proven beneficial to caregivers of her patients.


Q1 - What is palliative care and how do you get referred?

Professor Phillip Good provides a clear explanation of palliative care and addresses common misconceptions about the service. He also discusses the process of referrals, emphasising the importance of the relationship between the patient, the caregiver, and the referrer.

Q2 - About carers

Professor Phillip Good shares some profound insights into the lives of carers, exploring the challenges they encounter and their own emotional experiences in this role. He reveals the prevalent sense of guilt experienced by many carers, while also explaining the underlying reasons behind this common and natural feeling.

Q3 - How do you get referred to palliative care?

It is stressed by Professor Phillip Good that a doctor, be it a specialist or a general practitioner, should be the one to refer a patient to palliative care services. He explores the effects of early versus late referrals on a patient’s quality of life and underlines the holistic support that palliative care can offer.

Q4 - Supportive care

In relation to the term ‘palliative care’, Professor Phillip Good highlights the fact that although alternative names are used to refer to this service, he tries to clarify what is involved when asked, regardless of the terminology used.

Q5 - When is the right time to reach out to palliative care?

Professor Phillip Good explores the factors that should be considered when thinking about contacting palliative care and shares his views and some benefits of contacting the service earlier rather than later.

Q7 - What are the services available to patients living in remote areas?

Professor Phillip Good provides an overview of the telehealth palliative care service offered in rural Queensland. He details the operational process of the service and outlines the referral procedure for patients.

Q6 - What are your thoughts on CBD oil and alternative medication?

Professor Phillip Good starts by clarifying that CDB oil that is prescribed is not an ‘alternative’ medication. He notes that every prescription will have identical quantities of CBD in it, whereas this cannot be guaranteed with non-prescribed forms of cannabis. He also touches on the mistaken idea that cannabis cures cancer - there is no evidence of this - and he would be concerned if people chose untested medications as an ‘alternative’ to proven treatments.

Q8 - End of life care at home

In his findings, Professor Phillip Good discusses the statistics surrounding patients who die at home. He delves into the factors that influence where patients die and advises early preparation for those who have a preference to die in the comfort of their home.

Q10 - How does palliative care at home works?

Professor Phillip Good explains what a community palliative care service is and how it works. He explains the specialised skills that are available, such as counsellors and physiotherapists, and touches on equipment requirements. He then elaborates on the potential difficulties that patients and caregivers may encounter when administering care from home.

Q18 - Are some types of breast cancer more likely to metastasise to the brain?

Dr Rebecca Moor refers to ductal and lobular forms of breast cancer and the differences in their potential to metastasise to the brain. She talks about the advice she offers her patients on recognising symptoms that are specific to their particular type of cancer.

Q17 - Different types of scans

Dr Rebecca Moor provides a detailed explanation of the various scans utilised by oncologists during cancer treatment. She assesses the advantages and disadvantages of each type of scan, as well as their specific applications for different types of cancers.

Q16 - More about clinical trials

Dr Rebecca Moor explains how drug trials are conducted, what’s involved, and the factors that patients need to consider when thinking about joining a clinical trial.

Q15 - Clinical trials

Dr Rebecca Moor explains how drug trials are conducted, specifically around the use of placebos and the consequent impact on participating patients. She highlights the infrequency of trials where patients are exclusively administered placebos, attributing this to the many treatment options available.

Q14 - Bones

Dr Rebecca Moor provides detailed insights into the drug Denosumab, highlighting its role in complementing breast cancer treatments by alleviating bone pain and reducing the risk of fractures.

Q13 - Are women living longer with advanced breast cancer?

Dr Rebecca Moor outlines the therapies that have extended the lives of women with metastatic hormone positive cancer. She says that, in certain instances, the duration patients can remain on a specific medication has more than doubled. She then goes on to discuss advancements in new therapies for different cancer types.

Q12 - Finding solutions

Dr Rebecca Moor talks about what action can be taken if a patient feels like they are not being listened to by their oncologist. She suggests reasons as to why this may occur and offers advice for patients to attain a positive outcome.

Q11 - Liaising with your oncologist

Dr Rebecca Moor discusses the dynamics between a patient and their oncologist. She emphasises the evolving nature of this relationship and stresses the vital role of maintaining an open and ongoing dialogue between them.

Q10 - Pain relief and cannabis

Dr Rebecca Moor addresses the use of cannabis and its potential benefits for patients. She emphasises that the effectiveness of treatment varies among individuals, and her experience suggests that while some people have found it helpful for various reasons, others have not. She suggests that patients looking to try it inform their oncologist.

Q9 - Treatment options and hair loss

Dr Rebecca Moor elaborates on the differences in chemotherapy treatments for metastatic cancer, emphasising the need to take into account factors like quality of life when formulating a treatment plan. She also outlines specific chemotherapy options and the associated side effects.

Q8 - Can you go back on hormone treatment if other treatments stop working?

Dr Rebecca Moor explains that hormone positive breast cancers can develop resistance to hormone blocking therapies. And that unfortunately, once this resistance is established, the likelihood of hormone therapies regaining their effectiveness is minimal.

Q7 - Is there a link between sugar and cancer?

Dr Rebecca Moor addresses what she thinks may be the source of the perceived association between sugar and cancer but says that there is insufficient evidence to support the exclusion of sugar from a patient’s diet.

Q6 - Should we still have mammograms?

Dr Rebecca Moor explains that although mammograms are typically not necessary for individuals with metastatic breast cancer, there are certain circumstances in which an oncologist may recommend it for their patient.

Q5 - What are the problems associated with low calcium levels?

Dr Rebecca Moor discusses low calcium levels further, highlighting its impact on the digestive system but also the cardiovascular and renal systems. She elaborates on why oncologists conduct routine blood tests to monitor levels and ensure they remain within a healthy range.

Q4 - Is there a connection between breast cancer and dairy or soy products?

Dr Rebecca Moor addresses the misconception regarding the potential risk of dairy or soy products in relation to breast cancer. She clarifies the origins of such information and emphasises the lack of substantial research supporting any connection. Additionally, she highlights valid dietary concerns such as lactose intolerance that patients may take into consideration when deciding whether to include these products in their diet.

Q3 - What are the benefits of calcium supplements?

Dr Rebecca Moor addresses the consequences of low calcium levels and emphasises the role of diet in influencing these levels. She also highlights the significance of calcium supplements in ensuring the proper balance, particularly for individuals taking medications for bone health.

Q2 - Should we have bones density tests?

In a discussion on bone density, Dr. Rebecca Moor sheds light on the significance of Denosumab and Xgeva in alleviating bone pain and minimising fracture risks. She explains the role these medications, along with vitamins D and C, have in maintaining bone health. Additionally, she explains the guidelines regarding the requirement for bone density tests.

Q1 - Does Nexium affect the efficacy of Xgeva?

Dr Rebecca Moor discusses the impact of Nexium on calcium absorption and offers guidance on its proper intake alongside other medications. She also notes the effects of reflux on quality of life and the advice she gives her patients regarding PPI’s (Proton-pump inhibitors ie medications to reduce stomach acid).

Q10 - Palliative Care

Ms Head talks about the best time for a patient to consider palliative care and discusses its many benefits.

Q9 - Discussing Scan Results

Ms Crowe explains why it is preferable to discuss scan results with an oncologist before talking to a breast care nurse.

Q8 - More about the Role of the McGrath Nurse

Ms Crowe explains the McGrath Foundation’s model of care and how it governs the way they support patients. In addition, she delves into the various responsibilities that make up the role of a breast care nurse, shedding light on the tasks they undertake.

Q7 - How to Access CBD Oil

When inquiring about CBD oil, Ms Head suggests obtaining it through a prescription from an oncologist or palliative care physician. However, she notes that healthcare providers may be hesitant due to the lack of clinical trials. Ms Head emphasises the importance of discussing the use of CBD oil with a healthcare provider beforehand to ensure it does not interact with any other prescribed medications.

Q6 - Supportive Therapies

Ms Crowe discusses various supportive therapies and emphasises the importance of breast care nurses being knowledgeable about them, comprehending their significance, and effectively sharing this information with interested patients.

Q5 - Supporting Family Members

Pia inquires about support for family members and Ms Crowe explains that often with metastatic patients, it is common for nurses to engage in more conversations with family members than the patients themselves.

Q4 - Lobbying for Support

Ms Crowe talks about how the McGrath Foundation actively lobbies for new breast care nurses and funding. She also highlights that in a bid to increase numbers, the foundation is incorporating non-foundation nurses into their services.

Q3 - Regional Patients

Ms Crowe talks about how the McGrath Foundation strives to provide free access to a breast care nurse regardless of location. Additionally, she emphasises the benefits of being local and why she prefers to refer patients to a nurse in their area. Ms Head then gives further insights into the McGrath Foundation’s commitment to employing metastatic breast care nurses.

Q2 - Immunotherapy Response

Dr. Andelkovic sheds light on immunotherapy, stating that although research projects are underway, it has not yet become a mainstream treatment. He further elaborates how immunotherapy can serve as a viable option in areas where treatment options are limited e.g. triple negative breast cancer.

Q1 - On Referrals

Joining Dr Vlad Andelkovic Medical Oncologist for our question and answer session are Ms Katie Head and Ms Beth Crowe both Metastatic Breast Care Nurses. Ms Head discusses referrals and the different ways she might come into contact with new patients. Additionally, she mentions the McGrath Foundation’s commitment to employing specialist metastatic breast care nurses. Dr Andelkovic further elaborates how breast care nurses frequently possess knowledge of patients ahead of him.

Q13 - Why Does Cancer Recur?

Dr Andelkovic explains the various reasons why cancer can recur in some patients and provides details on some of these reasons. Additionally, he describes different types of recurrences and how oncologists would respond to them.

Q12 - Combination Therapies

Dr Andelkovic talks about how oncologists respond when drug combinations do not work for a patient. He gives examples of when a drug may need to be replaced with another.

Q11 - On Zoladex

Dr Andelkovic answers a question about Zoladex and explains its mechanism of action and why it can be used for a prolonged period. He also points out alternatives to this treatment and when a patient might consider this.

Q10 - The Uses of Radiation Therapy

Dr Andelkovic explains how and when radiation is used, which types of cancers it treats, and what benefits the patient receives from the treatment.

Q9 - Cumulative Effects of Long Term Treatment

Dr Andelkovic discusses the effects of specific medication when asked about long term treatment.

Q8 - Remission

Dr Andelkovic talks about when oncologists choose to use the term “remission” to describe a patient’s condition.

Q7 - Financial Implications of Outliving your Prognosis

Dr Andelkovic is asked about the financial implications of out-living a prognosis. He offers a medical perspective, talking about how these situations can arise when someone responds well to treatment.

Q6 - New Developments in Drug Treatment

Dr Andelkovic talks about a new treatment involving a new type of drug called antibody-drug conjugates or ADCs. He describes how they function and the benefits they offer.

Q5 - When Should Our Daughters Be Screened for Breast Cancer?

Dr Andelkovic discusses the appropriate time for daughters of breast cancer patients to undergo testing. He outlines the factors that are taken into account when determining the optimal timing for testing and how to begin this process.

Q4 - Genetic Testing

Dr Andelkovic is asked about genetic testing. He talks about how increasingly common it is becoming, before distinguishing between genetic and genomic testing. He then goes on to explain how the data obtained from these tests can be used to develop and apply certain treatments.

Q3 - On Team Work

Dr Andelkovic continues the discussion by explaining how oncologists work together in various ways and the advantages of sharing their experiences and challenges.

Dr Vikram Jain

Dr Vikram Jain QUESTION 1

QUESTION ONE: Understanding advanced breast cancer is not simply about the disease itself, but the journey (or detour) from diagnosis for the patient, their families and their medical team. In this video Dr Jain reflects on the difficulty associated with advanced breast cancer particularly in accepting that it is a disease that cannot be beaten.

Dr Vikram Jain QUESTION 2

QUESTION TWO: In this video Dr Jain’s uses an analogy of trying to get rid of weeds in a garden, as a way of explaining the difficultly of eradicating metastatic cancer cells in the body.

Dr Vikram Jain QUESTION 3

QUESTION THREE: Dr Jain references the three types of cancer and their sensitivity to chemo, specifically breast cancer and why responses to treatment in patients with advanced breast cancer do change over time. He also emphasises that the relationship between quantity and quality of life with respect to decision about treatment is incredibly personal.

Dr Vikram Jain QUESTION 4

QUESTION FOUR: In this video, Dr Jain is responding to a question from the group about immunotherapy and its relationship to breast cancer treatment.

Dr Vikram Jain QUESTION 5

QUESTION FIVE: In this 5th video, Dr Jain presents his thoughts about alternative therapies and particularly the importance to share any plans about using alternative therapies with your oncologist.

Dr Vikram Jain QUESTION 6

QUESTION SIX: The many roles of Aspirin are discussed by Dr Jain in this video, where he gives a general guide with respect to research into its effectiveness in breast cancer, particularly in early breast in managing the development of metastasis.

Dr Vikram Jain QUESTION 7

QUESTION SEVEN: A question came from the audience about the increased conversation about health, cancer and the effects of turmeric. Dr Jain’s response centred around the need for clinical evidence, particularly in recommending turmeric as a having a viable health benefit for patients.

Dr Vikram Jain QUESTION 8

QUESTION EIGHT: In discussing Palliative Care, Dr Jain recommends an earlier relationship with it by including it as part of a patients integrated cancer care programme. He stresses that it is no longer associated with end of life but rather as supportive care soon after diagnosis and throughout treatment. Overall, though, he emphasises the very personal decision about engaging with Palliative Care for patients.

Dr Vikram Jain QUESTION 9

QUESTION NINE: In this video, Dr Jain responds to a question about bone metastasis and treatment, including bone strengthening drugs. He also discusses the benefit of prophylactic intramedullary nails in weight bearing bones.

Dr Vikram Jain QUESTION 10

QUESTION TEN: Expanding on the response in the previous video about bone metastasis, Dr Jain explains flare responses or healing response in bones.

Dr Vikram Jain QUESTION 11

QUESTION ELEVEN: In this final video in the series with Dr Jain he gives his thoughts on diet and exercise and their role as part of treatment or simply good health and improved quality of life.